| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) | 
|---|
| 08/28/2014 | US20140242701 Chimeric antigen receptor | 
| 08/28/2014 | US20140242690 Cystic fibrosis treatment | 
| 08/28/2014 | US20140242640 Methods of Making Nanotechnological and Macromolecular Biomimetic Structures | 
| 08/28/2014 | US20140242635 Fermentation Process for the Production of Diphtheria Toxin | 
| 08/28/2014 | US20140242620 Method of inhibiting non-specific binding in step of detecting substance in biological sample, and agent for use in the method | 
| 08/28/2014 | US20140242114 cDNA CONSTRUCT OF SALMONIDAE ALPHAVIRUS | 
| 08/28/2014 | US20140242106 Staphylococcus aureus proteins and nucleic acids | 
| 08/28/2014 | US20140242105 Vaccines for chlamydia | 
| 08/28/2014 | US20140242104 Self-assembling peptide nanoparticles as vaccines against infection with norovirus | 
| 08/28/2014 | US20140242102 Influenza hemagglutinin and neuraminidase variants | 
| 08/28/2014 | US20140242089 Glycoproteins having lipid mobilising properties and therapeutic applications thereof | 
| 08/28/2014 | US20140242087 Modulation Of The VPS10p-Domain Receptor Family For The Treatment Of Mental And Behavioural Disorders | 
| 08/28/2014 | US20140242086 Polynucleotides encoding signal peptide-containing molecules | 
| 08/28/2014 | US20140242073 Cartilage/bone destruction suppressor | 
| 08/28/2014 | US20140242049 Mutant ctla4 gene transfected t cell and composition including same for anticancer immunotherapy | 
| 08/28/2014 | US20140242025 Multimeric il-15 soluble fusion molecules and methods of making and using same | 
| 08/28/2014 | US20140241999 Peptide linkers for effective multivalent peptide binding | 
| 08/28/2014 | US20140241993 Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer | 
| 08/28/2014 | US20140239237 Microbial nanowires and methods of making and using | 
| 08/27/2014 | EP2770055A1 Nucleic acid derived from hepatitis C virus, and expression vector, transformed cell and hepatitis C virus particles each prepared by using the same | 
| 08/27/2014 | EP2769991A1 Antibody targeting through a modular recognition domain | 
| 08/27/2014 | EP2769990A2 Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY | 
| 08/27/2014 | EP2769986A2 Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal | 
| 08/27/2014 | EP2769985A1 Aspergillus aculeatus derived polypeptides having C4-dicarboxylic acid transporter activity and polynucleotides encoding same | 
| 08/27/2014 | EP2769984A1 Fusion molecules and IL-15 variants | 
| 08/27/2014 | EP2769731A1 Methods to activate or block the HLA-E/QA-1 restricted CD8+ T cell regulatory pathway to treat immunological disease | 
| 08/27/2014 | EP2769220A1 Biomarker | 
| 08/27/2014 | EP2768961A1 Plants having enchanced yield-related traits and method for making the same | 
| 08/27/2014 | EP2768863A1 Anti-cd22 chimeric antigen receptors | 
| 08/27/2014 | EP2768854A1 Etanercept formulations stabilized with amino acids | 
| 08/27/2014 | EP2768853A1 Method for improving the stability of purified factor viii after reconstitution | 
| 08/27/2014 | EP2768852A1 Peptide compounds derived from melanotransferrin and uses thereof | 
| 08/27/2014 | EP2768851A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis | 
| 08/27/2014 | EP2768850A1 Novel peptides | 
| 08/27/2014 | EP2768849A1 Novel plant defensins and use in the treatment of proliferative diseases | 
| 08/27/2014 | EP2768848A1 Agents and methods for the expression and secretion of peptides and proteins | 
| 08/27/2014 | EP2768847A1 Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes | 
| 08/27/2014 | EP2768846A1 Methods for purifying erythropoietin analogs having lower isoelectric point | 
| 08/27/2014 | EP2768845A1 Separation method for fucosylated antibodies | 
| 08/27/2014 | EP2768844A1 Separation of acetylated proteins from unacetylated proteins | 
| 08/27/2014 | EP2768524A1 Pd-l1 based immunotherapy | 
| 08/27/2014 | EP2768520A1 Chemically and thermodynamically stable insulin analogues and improved methods for their production | 
| 08/27/2014 | EP2768518A1 Peptidomimetic macrocyles | 
| 08/26/2014 | US8816163 Soybean variety D2011911 | 
| 08/26/2014 | US8816162 Soybean variety A1026213 | 
| 08/26/2014 | US8816057 T1R taste receptors and genes encoding same | 
| 08/26/2014 | US8816054 Compositions and methods for enhancing coagulation Factor VIII function | 
| 08/26/2014 | US8816053 Methods for treating viral infection using IL-28 and IL-29 cysteine mutants | 
| 08/26/2014 | US8816052 Mutant apoprotein of photoprotein with low calcium sensitivity | 
| 08/26/2014 | US8816046 Compositions and methods for CaMKII inhibitors and uses thereof | 
| 08/26/2014 | US8815913 Metal-catalyzed copolymerization of imines and carbon monoxide as a route to synthesize polypeptides | 
| 08/26/2014 | US8815812 Synthetic arginine substituted peptides and their use | 
| 08/26/2014 | US8815811 Peptides and methods for their preparation and use | 
| 08/26/2014 | US8815810 Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain | 
| 08/26/2014 | US8815808 Modulation of activity of neurotrophins | 
| 08/26/2014 | US8815806 Yellow pea seed protein-derived peptides | 
| 08/26/2014 | US8815805 Formulations having an antagonist of α5β1 for anti-angiogenesis and cancer treatment | 
| 08/26/2014 | US8815804 Methods and compositions related to targeting tumors and wounds | 
| 08/26/2014 | US8815803 Method for increasing body height comprising systemic administration of CNP-53 | 
| 08/26/2014 | US8815802 GLP-1 analogues and derivatives | 
| 08/26/2014 | US8815798 Insulin analogues containing additional disulfide bonds | 
| 08/26/2014 | US8815795 Methods for preventing or treating eye diseases using adiponectin | 
| 08/26/2014 | US8815582 Mammalian cell expressing Volvox carteri light-activated ion channel protein (VChR1) | 
| 08/26/2014 | US8815573 Serum-free mammalian cell culture medium, and uses thereof | 
| 08/26/2014 | US8815541 Method for making polypeptides | 
| 08/26/2014 | US8815540 Productivity augmenting protein factor, novel cell lines and uses thereof | 
| 08/26/2014 | US8815525 Binding and functional assays that use the T1R3 receptor to screen for taste modulatory compounds | 
| 08/26/2014 | US8815501 Flavivirus NS1 subunit vaccine | 
| 08/26/2014 | US8815320 Process for producing a composition containing active follistatin | 
| 08/26/2014 | US8815295 Anti respiratory syncytial virus peptide functionalized gold nanoparticles | 
| 08/26/2014 | US8815277 In situ forming hydrogel and biomedical use thereof | 
| 08/26/2014 | US8815256 Induction of tumor immunity by variants of folate binding protein | 
| 08/26/2014 | US8815254 Method of detoxification | 
| 08/26/2014 | US8815251 Microbial delivery system | 
| 08/26/2014 | US8815250 Clotting factor-Fc chimeric proteins to treat hemophilia | 
| 08/26/2014 | US8815243 Pharmaceutical composition with antibody that binds to heat shock protein 27(HSP270) and method for promoting wound healing | 
| 08/26/2014 | US8815238 Methods for Preparing TACI-immunoglobulin fusion proteins | 
| 08/26/2014 | US8815230 Methods for treating Friedreich's ataxia with interferon gamma | 
| 08/26/2014 | US8815229 Granulysin in immunotherapy | 
| 08/26/2014 | CA2691539C Modified toxins | 
| 08/26/2014 | CA2476755C Compositions and methods for the therapy and diagnosis of inflammatory bowel disease | 
| 08/26/2014 | CA2467309C Type iii secretion pathway in aeromonas salmonicida, and uses therefor | 
| 08/26/2014 | CA2416472C Nucleic acids compositions conferring dwarfing phenotype | 
| 08/26/2014 | CA2390344C 85kda neisserial antigen | 
| 08/26/2014 | CA2373236C Combination neisserial compositions | 
| 08/21/2014 | WO2014127261A1 Chimeric antigen receptor and methods of use thereof | 
| 08/21/2014 | WO2014127231A1 Oligomeric influenza immunogenic compositions | 
| 08/21/2014 | WO2014127215A1 Optimized factor viii gene | 
| 08/21/2014 | WO2014127211A1 Deimmunized gelonin molecules and therapies | 
| 08/21/2014 | WO2014127084A1 Porcine parvovirus 5b, methods of use and vaccine | 
| 08/21/2014 | WO2014126986A1 Use of axmi184 for the control of rootworm insects | 
| 08/21/2014 | WO2014126884A1 High ph protein refolding methods | 
| 08/21/2014 | WO2014126876A1 Electrochemical processing of materials, methods and production | 
| 08/21/2014 | WO2014126681A1 Short bio-active peptides for promoting wound healing | 
| 08/21/2014 | WO2014126582A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF | 
| 08/21/2014 | WO2014125290A1 Scaffold proteins derived from plant cystatins | 
| 08/21/2014 | WO2014125164A1 A method for determining acute respiratory distress syndrome (ards) related biomarkers, a method to monitor the development and treatment of ards in a patient | 
| 08/21/2014 | WO2014124786A1 Polypeptides against plant pathogenic fungi | 
| 08/21/2014 | WO2014124540A1 Modified ingap peptides for treating diabetes | 
| 08/21/2014 | WO2014124487A1 Ligand binding molecules and uses thereof |